Regulatory News

The 340B Program: How Manufacturers, Plan Sponsors, and Brokers Should React

340B is increasingly a part of the pharmacy conversation. How should stakeholders react to the program?

Learn more →

Industry Update: The Impact of Recent State Legislation on Copay Accumulator Programs

Recently, several states have passed legislation that prohibits the use of copay accumulator adjustment programs. How does this affect your organization?

Learn more →